Search Tag: Pharma
2022 21 Jan
Thermo Fisher Scientific, Inc. has completed its acquisition of Wilmington-based global contract research organization PPD. The $17.4 billion deal was finalized in December. Thermo Fisher – which supports life sciences research by helping customers solve complex analytical challenges, improve patient diagnostics and therapies or increase the productivity...Read more
2019 26 Aug
Summary: The past, present & future of dementia care using sensors in everyday life objects through four use cases from research labs to large-scale pilots & adoption by pharmaceutical companies. Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder. It is the main cause of dementia, a syndrome defined by loss of cognitive...Read more
2019 26 Aug
Lions Health 2019 has offered new insights and discussions on how creativity is being embraced by the healthcare industry. Over two days, Lions Health 2019 offered new insights and fresh ideas on how creativity can be applied to improve healthcare through focussed discussion and knowledge. This year’s agenda included first-of-its-kind creativity covering...Read more
2019 22 May
How and where can precision medicine and public health join forces to improve patient care and outcomes and, ultimately, lead to more efficient healthcare. HealthManagement.org spoke to four precision medicine experts for their views. You might also like: Precision Medicine: the future of health Tienush Rassaf Department Head...Read more
2019 22 May
The promise of personalised medicine Based on extensive market research, the precision medicine sector is fast becoming a multibillion market. It consists of innumerable companies involved in the research and development, manufacturing and commercialisation of several novel drugs and diagnostic kits to boost the precision medicine workflow...Read more
2018 07 Nov
Why and how we need to assess patient centricity. Focusing on the issues and opportunities in quantifying patient engagement in pharma. It is an exciting time to be a member of the ‘patient economy’. For close to a decade pharma has worked relentlessly – sometimes seeming to run in circles – chasing the ‘perfect’ infrastructure to implement...Read more
2016 09 Feb
Medical and Healthcare systems around the world are facing an exceptional change. While healthcare is primarily organized within national geographies, the issues are truly global. Growing population and consumer expectations are creating significant challenges and opportunities in these sectors. UIML Expo is purely a dedicated International Exhibition...Read more
2015 02 Dec
PHARMCHINA is a large-scale proprietary event that puts buyers in direct contact with the Chinese pharmaceutical market. As the oldest fair of its kind, the National Drug Fair is a platform for services, trade, information exchange, and cooperation for pharmaceutical preparations, health products and related technology services in China and neighbor...Read more
2015 27 Feb
Ahead of its annual Congress in Hamburg, which is focused on the topic of patient safety, the European Association of Hospital Pharmacists (EAHP) has published a policy statement from its membership that calls for universal application of electronic prescribing across Europe in order to deliver a step change in medication error prevention. The statement...Read more
2014 14 May
Hospital pharmacists from 34 European countries gather for a unique Summit to tackle current diversities in health provision and set out the future services to be delivered by the profession. Alongside representatives from over 25 European patient organisations and associations representing other healthcare professionals, the Summit will deliver...Read more
2014 13 May
Patent expiry, together with an increase in generic competition in the global pharmaceutical and biotechnology industry, is expected to bring a number of deals. According to newly released analysis from Frost & Sullivan entitled “Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry”, evolving conditions...Read more
2013 20 Sep
A transformational new treatment for multiple sclerosis (MS) has been approved by the EU agency responsible for regulating new drugs. This is the result of over three decades of research in Cambridge. The European Medicines Agency (EMA) has approved the drug Alemtuzumab, to be known by the brand name Lemtrada and previously called Campath-1H...Read more
2013 23 Jul
Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published in EMBO Molecular Medicine, show that elevated levels of the protein Ret, which is short for “Rearranged during transfection”, are associated...Read more
2013 18 Jul
For the first time, more people in European Union (EU) countries are aged over 65 years than under 15 years. Much of the rest of the world, including low-and middle-income countries, is moving in a similar direction. A new WHO report calls for pharmaceutical researchers to adjust their research and development work to take account of this shift....Read more
2013 15 Jul
The European Association of Hospital Pharmacists (EAHP) is pleased to announce the Malta Association of Hospital Pharmacists (MAHP) and the Romanian Association of Hospital Pharmacists (ANFSR) as its newest members following the annual General Assembly of EAHP in Athens (14th-15th June 2013). Commenting on the continued growth of EAHP’s membership,...Read more
2013 11 Jul
The European Medicines Agency has established a formal Healthcare Professionals’ Working Party (HCPWP) to further involve this group of stakeholders in its range of activities. The role of the HCPWP is to provide recommendations to the Agency on all matters of interest to healthcare professionals in relation to medicines. The creation of this working...Read more